News

b

b

Current News in Drug Discovery

RSS Nature Reviews Drug Discovery
  • Stealthy polymer attacks Gram-negative bacteria July 2, 2025
    Nature Reviews Drug Discovery, Published online: 02 July 2025; doi:10.1038/d41573-025-00118-7Stealthy polymer attacks Gram-negative bacteria
    Katie Kingwell
  • Targeting the Hippo pathway in cancer June 30, 2025
    Nature Reviews Drug Discovery, Published online: 30 June 2025; doi:10.1038/s41573-025-01234-0The Hippo signalling pathway fulfils a vital role in the regulation of tissue homeostasis and organ development and its dysregulation is associated with several diseases. This Review provides an overview of Hippo pathway signalling and regulation, highlighting its biological functions and role in diseases. Recent advances […]
    Kieran F. Harvey
  • FDA approves first factor XIIa inhibitor, for hereditary angioedema June 27, 2025
    Nature Reviews Drug Discovery, Published online: 27 June 2025; doi:10.1038/d41573-025-00114-xFDA approves first factor XIIa inhibitor, for hereditary angioedema
    Asher Mullard
  • Metabolites as agents and targets for cancer immunotherapy  June 26, 2025
    Nature Reviews Drug Discovery, Published online: 26 June 2025; doi:10.1038/s41573-025-01227-zTumour cells undergo profound changes in their metabolism, but targeting these metabolic pathways requires understanding of the impact on immune cells as well as cancer cells. This Review discusses how metabolic pathways in cancer and immune cells shape the tumour microenvironment and describes metabolic modulators and […]
    Marcel P. Trefny
  • A neonatal window for in vivo gene therapy in haematopoietic stem cells June 26, 2025
    Nature Reviews Drug Discovery, Published online: 26 June 2025; doi:10.1038/d41573-025-00116-9A neonatal window for in vivo gene therapy in haematopoietic stem cells
    Alex Eccleston
  • Enhancing CAR-T cell efficacy through IFN ablation June 26, 2025
    Nature Reviews Drug Discovery, Published online: 26 June 2025; doi:10.1038/d41573-025-00115-wEnhancing CAR-T cell efficacy through IFN ablation
    M. Teresa Villanueva
  • Generative AI: a generation-defining shift for biopharma regulatory affairs June 25, 2025
    Nature Reviews Drug Discovery, Published online: 25 June 2025; doi:10.1038/d41573-025-00089-9As biopharmaceutical companies face mounting pressure to accelerate development timelines and improve the speed and quality of regulatory submissions, many are actively exploring the potential of generative artificial intelligence (GenAI) to transform how regulatory work gets done. This article examines how leading organizations are beginning to […]
    Jon Williams
  • Understanding semaglutide action in the brain June 24, 2025
    Nature Reviews Drug Discovery, Published online: 24 June 2025; doi:10.1038/d41573-025-00112-zUnderstanding semaglutide action in the brain
    Sarah Crunkhorn

Vitreon America™ Launches Botanicopeia™ Database and Federal Government Services at NIH Festival+

 BETHESDA, MD, September 17, 2016 − Vitreon America, Inc.™ participated this week in the National Institute of Health (NIH) Intramural Research Program’s 30th Annual NIH Research Festival which was held September 15-16, 2016 at the NIH Bethesda, Maryland campus.

The Festival included plenary sessions, symposia, exhibits, poster sessions and tours designed to encourage sharing and learning about the exciting research taking place on NIH campus.

Vitreon America™ was selected by the Technical Sales Association (TSA) which sponsors the Research Festival Exhibit, to launch its state-of-the-art Phytochemical and Ethnobotanical database subscription services, Botanicopeia™.

Attending on behalf of Vitreon America™
were Michael Megginson, VP of Business Development (left) and Jorgen Sandberg,
CEO (right).

Vitreon America was pleased to see the interest from the NIH Institutions to utilize the Botanicopeia™ database subscriptions with many NIH researchers expressing interest in considering the Vitreon America Botanical Research Analytic services as well to optimize the Botanicopeia™ database.

Based on the NIH researchers feedback, Vitreon America has established a Botanicopeia™ database subscription service agreement and subscription service with botanical research analytic services through Marshall Communications Corporation, www.marshallcomm.com.

Vitreon America services are available through Marshall Communications Corporation (VOSB) on NIH’s Information Technology Acquisition and Assessment Center’s (NITAAC)- Government-wide Acquisition Contract (GWAC) vehicle. [Prime Contract Holder #HHSN316201500063W]

Vitreon America™ was established with the goal of commercializing their Botanicopeia™ database and botanical research analytic services for development of botanicals and phytochemicals in the creation of new medicinal products by Vitreon America Clients.

To find out more about our Services please contact us for assistance at 1-888-214-2584 or at info@vitreonamerica.com

About Vitreon America™

Vitreon AmericaTM was formed with the goal of disseminating their BotanicopeiaTM database to encourage the increased use of botanicals and phytochemicals in the creation of new medicines.

Contact Vitreon America, Inc.

Vitreon America Botanical Research Center @ Hopkins Johns Hopkins University

MCC 9601 Medical Center Drive, Suite 221
Rockville, Maryland 20850

+1-888-214-2584

j.shaver@advasur.com